相关实验视频
Updated: Jun 12, 2025

07:17
Author Spotlight: Exploring Abdominal VNS for Inflammatory Conditions
Published on: January 19, 2024
1.7K
闭环多模式神经调节阴道神经以控制心率
Shane A Bender1, David B Green2, Kevin L Kilgore2
1Department of Physical Medicine and Rehabilitation, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
概括
这项研究引入了一种新的闭环系统,使用模糊逻辑控制来通过迷走神经刺激 (VNS) 和千赫兹频率交流电 (KHFAC) 调节心率. 该系统有效地调整和维持心率,证明了自主调节的潜力.
科学领域:
- 生物医学工程 生物医学工程
- 神经科学是一个神经科学.
- 控制系统 控制系统
背景情况:
- 自主调节需要双向的神经系统控制 (上调和下调).
- 现有的电神经调节系统需要实时适应生理变化.
- 神经刺激 (VNS) 频率调节神经活动,而千赫兹频率交替电流 (KHFAC) 阻断神经传导.
研究的目的:
- 开发和评估一个闭环神经调节系统,以实现精确的自主调节.
- 研究模糊逻辑控制 (FLC) 在管理复杂的生理反应中的有效性.
- 为了控制心率,使用VNS和KHFAC的组合通过在迷走神经上的双极电极传递.
主要方法:
- 一个单双极电极被手术放置在迷走神经上.
- 实现了一个模糊逻辑控制器 (FLC) 来管理刺激参数.
- 该系统提供了VNS (1-30 Hz) 进行神经激活和KHFAC进行神经抑制以控制心率.
主要成果:
- 在FLC成功地调整心率到目标值.
- 尽管有生理上的干扰,但系统保持了恒定的心率.
- 模糊逻辑控制在处理系统延迟和不连续性方面表现出强大.
结论:
- 使用FLC,VNS和KHFAC的闭环系统可以有效调节心率.
- 这种方法为双向自主神经系统调制提供了一个有前途的方法.
- FLC管理复杂系统动态的能力对于实时自主控制至关重要.
相关概念视频
Regulation of Heart Rates
1.7K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
1.7K
Mechanism of Cardiac Arrhythmias
899
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
899
Electrophysiology of Normal Cardiac Rhythm
2.3K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
2.3K
Motor Unit Stimulation
1.5K
When the neuron of a motor unit fires an action potential, it triggers a series of events, leading to a twitch contraction in the muscle fibers. The process of excitation-contraction coupling is crucial in relaying the action potential to the muscle fibers.
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...
1.5K
Heart Failure Drugs: Inotropic Agents
539
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
539
Drugs Acting on Autonomic Ganglia: Blockers
979
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
979

